Found: 5
Select item for more details and to access through your institution.
Safety, Tolerability, and Preliminary Efficacy of 48 Weeks of Etravirine Therapy in a Phase IIb Dose-Ranging Study Involving Treatment-Experienced Patients with HIV-1 Infection.
- Published in:
- Clinical Infectious Diseases, 2008, v. 47, n. 7, p. 969, doi. 10.1086/591705
- By:
- Publication type:
- Article
Effects of Different Meal Compositions and Fasted State on the Oral Bioavailability of Etravirine.
- Published in:
- Pharmacotherapy, 2008, v. 28, n. 10, p. 1215
- By:
- Publication type:
- Article
Pharmacokinetic evaluation of the interaction between etravirine and rifabutin or clarithromycin in HIV-negative, healthy volunteers: results from two Phase 1 studies.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 3, p. 728, doi. 10.1093/jac/dkt421
- By:
- Publication type:
- Article
A pharmacokinetic study of etravirine (TMC125) co-administered with ranitidine and omeprazole in HIV–negative volunteers.
- Published in:
- British Journal of Clinical Pharmacology, 2008, v. 66, n. 4, p. 508, doi. 10.1111/j.1365-2125.2008.03214.x
- By:
- Publication type:
- Article
Pharmacokinetic interaction between TMC114/ritonavir and tenofovir disoproxil fumarate in healthy volunteers.
- Published in:
- British Journal of Clinical Pharmacology, 2007, v. 64, n. 5, p. 655, doi. 10.1111/j.1365-2125.2007.02957.x
- By:
- Publication type:
- Article